The research delves into the varying sedation techniques employed during the double-balloon endoscopic retrograde cholangiopancreatography (DB-ERCP) procedure, a topic of debate among medical professionals worldwide. The core objective was to gauge the performance of propofol sedation, administered by non-anesthesiologists, using a target-controlled infusion (TCI) mechanism in DB-ERCP.
Spanning from May 2017 to December 2020, this retrospective analysis encompassed 156 DB-ERCP patients. These individuals were either given diazepam or propofol via a TCI system for sedation. The main focus was on contrasting the instances of inadequate sedation between the two methods. The findings revealed a higher occurrence of insufficient sedation with diazepam. Moreover, pronounced body movements and reduced oxygen levels were more prevalent among diazepam recipients.
A detailed analysis pinpointed younger age (below 70), a BMI exceeding 25 kg/m^2, and the use of propofol as factors contributing to inadequate sedation. In conclusion, the TCI system’s propofol sedation method for DB-ERCP proved to be a safer and superior alternative to diazepam.